Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial

Documents similaires

• Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
  par: Koster, Bas D., et autres
  Publié: (2019)
• Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node
  par: van den Hout, Mari F. C. M., et autres
  Publié: (2016)
• Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread
  par: van den Hout, Mari F, et autres
  Publié: (2013)
• Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
  par: de Gruijl, Tanja D., et autres
  Publié: (2008)
• Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials
  par: de Gruijl, Tanja D, et autres
  Publié: (2015)